Add BrightSurf on Google Email

Study finds sex- and race-based disparities in IBS diagnosis rates among US adults

A national survey found significant disparities in IBS diagnosis across sex and racial groups in the US. Men and Black patients are less likely to receive a formal diagnosis compared to women and white patients, despite similar reported healthcare-seeking behavior and symptom severity.

SourceUniversity of California - Los Angeles Health Sciences·JournalClinical Gastroenterology and Hepatology·TypeData/statistical analysis·DateApr 9, 2026

How fetal reversion supports intestinal regeneration and preserves stem cells

Researchers from Institute of Science Tokyo discovered a unique mechanism in which conventional stem cells can temporarily switch into a specialized regenerative state called revival stem cells, driving tissue repair. This process, known as fetal reversion, enables efficient regeneration without exhausting the stem cell pool.

SourceInstitute of Science Tokyo·JournalCommunications Biology·TypeExperimental study·DateMar 27, 2026

Fiber in whole wheat foods protects against gut inflammation in mice, study finds

Researchers found that metabolism of wheat fiber by intestinal bacteria generated bioactive anti-inflammatory metabolites, including polyphenols, which reprogrammed intestinal immune cells to suppress inflammation. The study suggests eating whole wheat foods may reduce one’s risk of developing inflammatory bowel disease (IBD).

SourceGeorgia State University·JournalScience Advances·TypeExperimental study·DateMar 25, 2026

Phase 3 study: New therapy keeps gastrointestinal cancer care on course when low platelets are an obstacle

A phase 3 clinical trial found romiplostim significantly reduced chemotherapy dose delays and improved platelet counts in patients with gastrointestinal cancers who developed persistent low platelet counts during treatment. The therapy enables patients to maintain chemotherapy intensity, potentially preserving the integrity of cancer c...

SourceUniversity of Miami Miller School of Medicine·JournalNew England Journal of Medicine·DateMar 16, 2026

Early life stress linked to long-lasting digestive issues

A new study suggests that early life stress during pregnancy and early childhood can lead to long-term digestive issues, including gut pain and motility challenges. The research found that early life stress can shape the development of gut-brain communication, contributing to gastrointestinal symptoms in both mice and humans.

SourceNew York University·JournalGastroenterology·DateMar 16, 2026

An experimental model reproduces creeping fat associated with Crohn's disease and facilitates its study

A new experimental rat model reproduces creeping fat in Crohn's disease, characterized by mesocolic adipose tissue hyperplasia with macroscopic, histological, immunological, and molecular similarities to human disease. The model supports the hypothesis that intestinal microbiota contributes to remodelling of mesenteric adipose tissue.

SourceGermans Trias i Pujol Research Institute·JournalInflammatory Bowel Diseases·TypeExperimental study·DateMar 11, 2026

Mount Sinai and King Saud University Medical City forge a three-year collaboration to advance precision medicine in familial inflammatory bowel disease

The collaboration aims to understand why IBD runs in some Saudi families and develop personalized treatment options. By studying well-characterized families with multiple members affected, researchers hope to identify exposure and biological markers that drive disease mechanisms and outcomes.

Study finds lack of Angptl4 gene triggers long-term protection against inflammatory bowel disease by reprogramming the immune system

Researchers found that mice without the ANGPTL4 gene were protected from intestinal inflammation and colon tumors due to altered macrophage behavior. The study suggests that early-life inflammatory events can shape long-term immune programming, providing resistance to future challenges.

SourceElsevier·JournalAmerican Journal Of Pathology·TypeExperimental study·DateFeb 18, 2026

DNA ties gut motility to vitamin B1

A new study found that genetic differences in vitamin B1 transport and activation are linked to bowel movement frequency, highlighting potential new pathways for research on gut motility disorders. The analysis also supports the idea of a biological overlap between bowel movement frequency and IBS.

SourceCIC bioGUNE·JournalGut·DateJan 20, 2026

Fat surrounding the colon interacts with the immune system

Research reveals that fat located near the colon contains an unusually high number of inflammatory fat cells and immune cells, suggesting a unique function in communicating with the immune system in the gut region. This tissue may be an adaptation to the gut microbiome and could contribute to amplifying or sustaining inflammation.

SourceKarolinska Institutet·JournalCell Metabolism·TypeExperimental study·DateJan 13, 2026

Lifesaving breakthrough in bacterial behavior

Researchers have made a groundbreaking discovery about how bacteria swim upstream to cause infections, pointing to new designs for biomedical devices that can prevent contamination. The study found that wider channels with faster counterflows are more prone to invasion, but sharp corner designs can inhibit bacterial growth.

SourceUniversity of Pennsylvania·JournalNewton·TypeExperimental study·DateJan 12, 2026

Research paves the way for safer colonoscopy bowel prep for people with compromised gut health

A new study found that bowel preparation procedures for colonoscopies can disrupt the gut environment, making mice more susceptible to infection and inflammation. The researchers hope to understand whether these procedures may put people with inflammatory bowel disease (IBD) at risk of exacerbation.

SourceUniversity of British Columbia·JournalCell Reports Medicine·TypeObservational study·DateJan 8, 2026

American Gastroenterological Association streamlines Crohn’s disease treatment guidance as new therapies expand options

The American Gastroenterological Association has released an updated clinical guideline on the pharmacological management of moderate-to-severe Crohn’s disease, recommending early use of high-efficacy therapies to improve patient outcomes. The guideline organizes treatments by efficacy to simplify decision-making for gastroenterologist...

SourceAmerican Gastroenterological Association·JournalGastroenterology·TypeNews article·DateNov 20, 2025

Semaglutide, tirzepatide, and dulaglutide have similar gastrointestinal safety profiles in clinical settings

A new observational study found that semaglutide, tirzepatide, and dulaglutide have similar gastrointestinal safety profiles among patients with type 2 diabetes. The medications were assessed in a large database of adults with T2D, who underwent treatment with these GLP-1 RA medications between 2019 and 2024.

SourceAmerican College of Physicians·JournalAnnals of Internal Medicine·TypeNews article·DateNov 3, 2025

Experts urge risk-based monitoring as Barrett’s esophagus care moves beyond one-size-fits-all

The new American Gastroenterological Association guideline emphasizes the need for regular monitoring in many patients with Barrett's esophagus who do not exhibit dysplasia or cancerous changes. The guideline also recommends using high-definition white-light endoscopy in combination with chromoendoscopy to improve detection of Barrett'...

SourceAmerican Gastroenterological Association·JournalGastroenterology·DateOct 20, 2025

Crohn’s & Colitis Foundation and international partners launch GLIDE: An integrated global registry to advance IBD care

The Crohn's & Colitis Foundation has launched GLIDE, an integrated global registry to connect patient data from IBD registries worldwide. This initiative aims to accelerate insights into complex clinical questions, driving improvements in care for those living with Crohn's disease and ulcerative colitis.

Gut infections often overlooked in men who have sex with men

A new review article highlights the need for effective control and prevention strategies for sexually transmitted gut infections, which can persist longer and be harder to treat. The authors emphasize the importance of prompt diagnosis, appropriate treatment, and community-level education and testing.

SourceUniversity of Washington School of Medicine/UW Medicine·JournalClinical Microbiology Reviews·TypeLiterature review·DateSep 17, 2025

Are probiotics worth the cost to prevent infection after a colon removal surgery?

A UCLA Health study found that taking an 8-strain probiotic daily reduces the risk of pouchitis, a common inflammatory condition. However, the treatment's cost-effectiveness depends on the patient's likelihood of flare-ups, with benefits only seen in patients with frequent relapses.

SourceUniversity of California - Los Angeles Health Sciences·JournalGastro Hep Advances·TypeComputational simulation/modeling·DateSep 3, 2025

First global guidelines for pregnancy and inflammatory bowel disease developed

The global consensus conference aims to provide standardized, evidence-based recommendations for providers caring for women with IBD during pregnancy. The guidelines include continuing biologics throughout pregnancy and lactation, preconception counseling, and administering the rotavirus vaccine on schedule.

SourceUniversity of California San Francisco Medical Center·JournalClinical Gastroenterology and Hepatology·TypeLiterature review·DateAug 28, 2025

Transcutaneous vagal nerve stimulation for gastrointestinal disorders

This review synthesizes evidence from clinical trials on the efficacy of transcutaneous vagal nerve stimulation (tVNS) in managing abdominal pain, improving gastrointestinal symptoms, and enhancing motility in disorders such as functional dyspepsia, gastroparesis, irritable bowel syndrome, and inflammatory bowel disease. tVNS demonstra...

SourceXia & He Publishing Inc.·JournalJournal of Translational Gastroenterology·DateAug 27, 2025

AI analysis of colonoscopy improves assessment of Crohn’s disease

A new study published in Clinical Gastroenterology and Hepatology shows that AI analysis can accurately identify mucosal ulceration as well as human reviewers, providing a more objective and reproducible assessment of Crohn's disease. The findings have potential implications for education, drug development, and automated care.

SourceMichigan Medicine - University of Michigan·JournalClinical Gastroenterology and Hepatology·TypeImaging analysis·DateAug 27, 2025